The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Nexavar (Sorafenib) for RAF mutation please help

javier_garcia123
javier_garcia123 CSN Member Posts: 28
in Colorectal Cancer #1

I need to know how good is Nexavar (Sorafenib) at targeting RAF1 mutation, I ask this because Mom used Foundation One, have this mutation, and one of three Targeted Therapies recommended is Sorafenib, the other two being Regorafenib and Trametinib

 

 

The mutation is related to cell division pathway called the MAPK path: MAPK>RAS>RAF>MEK>CCNE1

 

 

 

Also, how to avoid as much as we can nausea? and if you can tell the most frequent side effects in practise and ways to avoid them

Like Care

Comments

Discussion Boards